Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Swallowable cancer immune therapy being developed

Apeiron Biologics CEO Hans Loibner said: "Our concept is that we would like to develop small molecule (synthetically produced) substances which provide the immune system with specific properties.” Apeiron and Evotec established a screening system to search through a substance library containing about 100,000 substances to find an enhancing effect on immune cells. Several drug candidates were discovered within the context of the project APN411.

In contrast to monoclonal antibodies, the new drug candidates showed in laboratory tests that they could trigger several effects in the immune cells. These produce more of the anti-tumor messenger substances interleukin-2, interferon gamma and tumor necrosis factor alpha. The T-cells showed enhanced activity.  

It is also decisive for the project that the substances are small and can be very effectively produced on an industrial scale.  

Apeiron, founded by Josef Penninger, Head of the Institute for Molecular Biotechnology in Vienna (IMBA), is already involved in early clinical tests in the USA with APN401, another cancer checkpoint project. A medicine developed by Apeiron to treat brain tumors in children is awaiting approval by the European Medicines Agency (EMA). 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Pan-Nordic & DACH Innovation&Investment Roadshow

    21.09.2018, Kunshan, China

  • Österriech. Raum für Ideen.

    25.09.2018, Stuttgart, Germany

Austria Map

Find the perfect location for your company

Vienna is the driving force for innovations in our company,
and one of the growth drivers.

Ottobock Austria

Logo
More testimonials

news from the business location Austria

September 12-14, 2018: 1MillionStartups Global Conference in Vienna

The Viennese startup hub weXelerate is hosting the very first 1MillionStartups Global Conference from September 12-14, 2018.

Austria: Business Location for Savvy Corporate Minds

Austria’s central location combined with an excellent infrastructure enabling all of Europe to be reached within three hours flight time has always lured companies. However, Austria has a lot more to offer the international business community than these advantages.

More news All blog posts